Table 2.
Comparison of Blood Inflammation Biomarker in the Study Patients by Survival Status
| Characteristic | Survive (n = 426) | Death (n = 85) | P value |
|---|---|---|---|
| Neutrophil percentage (median [IQR]) | 0.7 (0.6, 0.7) | 0.8 (0.6, 0.9) | <0.001 |
| Lymphocytes percentage (median [IQR]) | 0.2 (0.2, 0.3) | 0.2 (0.1, 0.2) | <0.001 |
| Platelet count, 109/L (median [IQR]) | 162.5 (118.0, 215.0) | 141.0 (91.0, 180.0) | 0.001 |
| Albumin, g/L (median [IQR]) | 34.5 (31.9, 37.1) | 33.2 (30.3, 35.9) | 0.004 |
| NPAR (median [IQR]) | 19.0 (16.3, 22.0) | 22.7 (18.6, 26.6) | <0.001 |
| T1 (≤17.5) | 151 (35.4) | 18 (21.2) | <0.001 |
| T2 (17.5–21.3) | 151 (35.4) | 17 (20.0) | |
| T3 (>21.3) | 124 (29.1) | 50 (58.8) | |
| NLR (median [IQR]) | 3.1 (2.1, 4.7) | 4.8 (3.0, 10.8) | <0.001 |
| T1 (≤2.5) | 152 (35.7) | 17 (20.0) | <0.001 |
| T2 (2.5–4.3) | 147 (34.5) | 21 (24.7) | |
| T3 (>4.3) | 127 (29.8) | 47 (55.3) | |
| PLR (median [IQR]) | 125.6 (85.3, 176.2) | 123.1 (87.6, 181.4) | 0.761 |
| T1 (≤99.3) | 140 (32.9) | 29 (34.1) | 0.886 |
| T2 (99.3–155.0) | 142 (33.3) | 26 (30.6) | |
| T3 (>155.0) | 144 (33.8) | 30 (35.3) |
Abbreviations: IQR, interquartile range; NPAR, neutrophil percentage-to-albumin ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.